SCHEDULE: T. Rowe Price Discloses 12.1% Stake in Personalis Inc.

T. Rowe Price Investment Management, Inc. has reported a 12.1% beneficial ownership stake in Personalis Inc. as of December 31, 2025.

Summary

• T. Rowe Price Investment Management, Inc. filed a Schedule 13G for Personalis Inc.
• The filing indicates beneficial ownership of 10,780,290 shares of Common Stock.
• This represents 12.1% of the class of securities.
• T. Rowe Price holds sole voting power over 10,780,290 shares and sole dispositive power over 10,780,290 shares.
• The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 7

Explanation: The filing indicates a significant passive institutional investment by a reputable firm, T. Rowe Price, which is generally a positive signal for the company's long-term prospects, even though it's a routine disclosure.

Positives

• A major institutional investor, T. Rowe Price Investment Management, Inc., holds a significant stake (12.1%) in Personalis Inc., which can be seen as a vote of confidence.
• The filing explicitly states the securities were acquired and are held in the ordinary course of business, not for control purposes, suggesting a passive investment strategy.

Future Outlook

NA

Management Comments

• T. Rowe Price Investment Management, Inc. hereby declares and affirms that the filing of Schedule 13G shall not be construed as an admission that Price Investment Management is the beneficial owner of the securities referred to, which beneficial ownership is expressly denied.
• By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §§ 240.14a-11.

Industry Context

This filing indicates a significant institutional investment in Personalis Inc., a company likely operating in the biotechnology or genomics sector given its name. Such investments are common for growth-oriented companies in these industries, reflecting institutional interest in their long-term potential.

Stakeholder Impact

• Shareholders: Increased institutional ownership may provide stability and confidence in the company's long-term prospects.
• Management: Awareness of a significant passive institutional investor in the company's stock.

Key Dates

Recommendation

This Schedule 13G filing indicates T. Rowe Price Investment Management, Inc. holds a significant 12.1% passive stake in Personalis Inc. While this is a positive signal of institutional confidence, the filing itself does not provide operational or financial performance data to warrant a 'buy' or 'sell' recommendation. It primarily confirms a substantial, non-activist investment, suggesting a 'hold' position for current investors.

Keywords

Personalis Inc, T. Rowe Price, Schedule 13G, Common Stock, Institutional Ownership, Investment Management, Biotechnology, Genomics